Connecting to SEC EDGAR… PricingSign in
← All filings

DNLI

Denali Therapeutics Inc. SEC filings
Biological Products, (No Diagnostic Substances) · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for DNLI right now.
Filing history
2026-11-03
Quarterly report 10-Q
Filing ↗
2026-11-03
Current report 8-K
Earnings results
Filing ↗
2026-09-09
Insider trade 4
Filing ↗
2026-09-04
Planned insider sale 144
Filing ↗
2026-09-04
Insider trade 4
Filing ↗
2026-09-03
Insider trade 4
Filing ↗
2026-09-02
Planned insider sale 144
Filing ↗
2026-09-01
Planned insider sale 144
Filing ↗
2026-08-14
Insider trade 4
Filing ↗
2026-08-13
Insider trade 4
Filing ↗
2026-08-11
Planned insider sale 144
Filing ↗
2026-08-06
Quarterly report 10-Q
Filing ↗
2026-08-06
Current report 8-K
Earnings results
Filing ↗
2026-08-04
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-07-28
Current report 8-K
Acquisition/sale completed
Filing ↗
2026-07-08
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-06-18
Current report 8-K
Material agreementReg FD disclosure
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-05
Insider trade 4
Filing ↗
2026-06-04
Current report 8-K
Shareholder vote
Filing ↗
2026-05-22
Current report 8-K
Reg FD disclosure
Filing ↗
2026-05-15
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-05-07
Quarterly report 10-Q
Filing ↗
2026-05-07
Current report 8-K
Earnings results
Filing ↗
2026-05-06
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-04-21
3/A 3/A
Filing ↗
2026-04-21
Proxy material DEFA14A
Filing ↗
2026-04-21
Annual report to shareholders ARS
Filing ↗
2026-04-21
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-04-20
New insider's holdings 3
Filing ↗
2026-04-03
Current report 8-K
Agreement ended
Filing ↗
2026-03-31
Current report 8-K
New debtReg FD disclosure
Filing ↗
2026-03-26
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-03-25
Current report 8-K
Reg FD disclosure
Filing ↗